19 Nov 2020
Posted by Andrew Kantor
Pfizer and BioNTech say the final analysis of their Covid-19 vaccine shows it’s 95 percent effective — take that Moderna, with your measly 94.5% effectiveness.
More people say they’ll get it, too.
And in case it matters, Moderna has the Dolly Parton seal of approval.
There’s always that guy who has to spoil the party. For today, the role will be played by The New York Times, Politico, and Bloomberg.
NYT: “The Vaccines Will Probably Work. Making Them Fast Will Be the Hard Part*.”
Politico: “Inoculations by December? States aren’t so sure.”
Bloomberg: “Vaccine Safety to Remain Unclear Until Millions Get Their Shots”
While it looks like we’re heading to the pandemic endgame (the “last big surge“), don’t forget that the situation is still six shades of awful. A vaccine won’t help anyone who gets Covid-19 over the holidays. Is the Joy of Family™ worth the risk of permanent heart, lung, and even brain damage?
Georgia’s case numbers are going up, if you haven’t heard — we’re not being spared this latest wave.
If it helps, Zoom is removing the 40-minute time limit for free meetings on Thanksgiving. So prop up that cam and keep it virtual just this once.
Two studies seem to show that Covid-19 immunity will last months.
“An Emerging Ebola-Like Virus in Bolivia Can Spread Between Humans, Scientists Find”
Kudos to WellStar’s Laura Pearson — the oncologist, surgeon, and breast program medical director was featured in the Cobb County Courier talking about breast cancer awareness.
“[T]he good news in all of this is we’re actually really good at taking care of breast cancer. And so even if somebody is diagnosed with breast cancer, the likelihood of them getting through treatment and going on to live a long productive life is, is really good.”
It’s not just Op Warp Speed. Basic research paid for by the government over decades — from lipids and proteins to mRNA — paved the way for nearly all the Covid-19 vaccines in development.